Grant ID

14T-001

Illness

schizophrenia

Primary Drug/Intervention

estradiol

Primary Dosage

200 ug/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Weiser

Sample Size

200

Duration of Study Period for Each Subject

56 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Mark Weiser

Degree

MD

Center

Sheeba Hospital

Institution

Tel Aviv University

Address

City or Town

Ramat Gan

State or Province

N/A

Zip or Postal Code

N/A

Country

Israel

Email Address

mweiser@netvision.net.il